Recently, amplification of CCNE1 or PRKCI has been reported to promote HGSOC, by enhancing an immunosuppressive tumor microenvironment in the case of PRKCI amplification (7), conferring chemoresistance in OV (43). The gene discussed is CCNE1; the disease is neoplasm.